St. Jude shares shine with Goldman upgrade

Amid a broad selloff, shares of St. Jude Medical tick higher as Goldman Sachs upgrades its rating on the stock to a “buy.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.